Javascript must be enabled to continue!
Expression of Recombinant Factor IX Using the Transient Gene Expression Technique
View through CrossRef
Background: Pilot and large-scale production of recombinant proteins require the presence of stable clones, but the process of selecting stable clones is time consuming. Moreover, continuous clone culturing in large-scale production may cause loss of incoming plasmid and recombinant genes. Considering the advancements in Transient Gene Expression (TGE) technology, the large-scale expression of factor IX (FIX) was investigated in HEK cells by the TGE technique. Materials and Methods: HEK cells were seeded in a cell factory, and then transfected by pcDNA-hFIX plasmid using calcium phosphate co-precipitation method. Stable HEKhFIX cells were also seeded in a cell factory, separately. After adding vitamin K, recombinant FIX was quantified in conditioned media using an ELISA. Moreover, its functional activity was assayed using an aPTT test. Results: The results showed that the expression and activity of FIX by TGE technology was, respectively, 1.6 and 1.5 times higher than that obtained through stable HEK-FIX cells. Since calculating the specific activity revealed that for all time periods it is 0.2 mU/ng, so the increase in activity is due to the increase in the amount of FIX. Conclusions: HEK cells with higher transfectability seemed to be an appropriate alternative for transient expression for large-scale protein production. Furthermore, if rapid expression of recombinant proteins is intended, TGE can replace costly and lowyield methods.
Negah Scientific Publisher
Title: Expression of Recombinant Factor IX Using the Transient Gene Expression Technique
Description:
Background: Pilot and large-scale production of recombinant proteins require the presence of stable clones, but the process of selecting stable clones is time consuming.
Moreover, continuous clone culturing in large-scale production may cause loss of incoming plasmid and recombinant genes.
Considering the advancements in Transient Gene Expression (TGE) technology, the large-scale expression of factor IX (FIX) was investigated in HEK cells by the TGE technique.
Materials and Methods: HEK cells were seeded in a cell factory, and then transfected by pcDNA-hFIX plasmid using calcium phosphate co-precipitation method.
Stable HEKhFIX cells were also seeded in a cell factory, separately.
After adding vitamin K, recombinant FIX was quantified in conditioned media using an ELISA.
Moreover, its functional activity was assayed using an aPTT test.
Results: The results showed that the expression and activity of FIX by TGE technology was, respectively, 1.
6 and 1.
5 times higher than that obtained through stable HEK-FIX cells.
Since calculating the specific activity revealed that for all time periods it is 0.
2 mU/ng, so the increase in activity is due to the increase in the amount of FIX.
Conclusions: HEK cells with higher transfectability seemed to be an appropriate alternative for transient expression for large-scale protein production.
Furthermore, if rapid expression of recombinant proteins is intended, TGE can replace costly and lowyield methods.
Related Results
Expression and polymorphism of genes in gallstones
Expression and polymorphism of genes in gallstones
ABSTRACT
Through the method of clinical case control study, to explore the expression and genetic polymorphism of KLF14 gene (rs4731702 and rs972283) and SR-B1 gene...
Reverse Genetics with a Full-length Infectious cDNA Clone of Bovine Torovirus
Reverse Genetics with a Full-length Infectious cDNA Clone of Bovine Torovirus
Abstract
Torovirus (ToV) has recently been classified in the new family Tobaniviridae, although it belonged to the Coronavirus (CoV) family historically. Reverse ge...
Experimental immunization of mice with a recombinant bovine enterovirus vaccine expressing BVDV E0 protein elicits a long-lasting serologic response
Experimental immunization of mice with a recombinant bovine enterovirus vaccine expressing BVDV E0 protein elicits a long-lasting serologic response
AbstractBackgroundBovine viral diarrhea virus (BVDV) is a cause of substantial economic loss to the cattle industry worldwide, and there are currently no effective treatment or pre...
The Prognostic Impact of High MEL1 Gene Expression in Pediatric Acute Myeloid Leukemia
The Prognostic Impact of High MEL1 Gene Expression in Pediatric Acute Myeloid Leukemia
Abstract
Background
Acute myeloid leukemia (AML) is a complex disease caused by mutations, epigenetic modifications, and deregulated expression of gen...
Recombinant thrombomodulin and recombinant antithrombin attenuate pulmonary endothelial glycocalyx degradation and neutrophil extracellular trap formation in ventilator-induced lung injury
Recombinant thrombomodulin and recombinant antithrombin attenuate pulmonary endothelial glycocalyx degradation and neutrophil extracellular trap formation in ventilator-induced lung injury
Abstract
Background: Vascular endothelial damage is involved in the development and exacerbation of ventilator-induced lung injury (VILI). Pulmonary endothelial glycocalyx ...
ANALISIS KETERKAITAN KEKERASAN DENGAN PERBUATAN CABUL TERHADAP ANAK
ANALISIS KETERKAITAN KEKERASAN DENGAN PERBUATAN CABUL TERHADAP ANAK
<span id="page3R_mcid85" class="markedContent"><em><span style="left: calc(var(--scale-factor)*85.10px); top: calc(var(--scale-factor)*399.05px); font-size: calc(var...
CONSTRUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS SEROTYPE 9 WITH RIBOZYME GENE TARGETING NF-κB AND ITS SUPPRESSION OF NF-κB ACTIVITY IN HELA CELLS
CONSTRUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS SEROTYPE 9 WITH RIBOZYME GENE TARGETING NF-κB AND ITS SUPPRESSION OF NF-κB ACTIVITY IN HELA CELLS
Objectives
To construct the recombinant adeno-associated virus serotype 9 containing ribozyme gene (R65) targeting nuclear factor-κ B (NF-κB), and investigate the...
Expression of Wnt-Inhibitors and SDF-1 in Whole Bone Marrow Biopsies in Association to the Osteolytic Bone Disease of Multiple Myeloma.
Expression of Wnt-Inhibitors and SDF-1 in Whole Bone Marrow Biopsies in Association to the Osteolytic Bone Disease of Multiple Myeloma.
Abstract
Abstract 2922
Osteolytic bone disease (OBD) in multiple myeloma (MM) is caused by a combination of osteoclast hyperactivation and osteoblast ...

